Al-Modawat Specialized Medical Co.’s net profit leapt 80% to SAR 18.6 million in 2023, from SAR 10.3 million a year earlier.
Item | 2022 | 2023 | Change |
---|---|---|---|
Revenues | 58.57 | 74.31 | 26.9 % |
Gross Income | 28.52 | 40.63 | 42.5 % |
Operating Income | 11.44 | 20.17 | 76.3 % |
Net Income | 10.31 | 18.59 | 80.3 % |
Average Shares | 19.00 | 19.00 | - |
EPS (Riyals) | 0.54 | 0.98 | 80.3 % |
The company posted higher revenues due to the opening of new departments such as neurology and the increase in the number of internists.
Total shareholders’ equity, no minority interest, stood at SAR 39.25 million by the end of 2023, compared to SAR 30.98 million a year before.
Historical Data |
|||
Period |
Revenues (SAR mln) |
Net Profit (SAR mln) |
EPS (SAR) |
H1 2022 |
25.30 |
3.64 |
1.92 |
H2 2022 |
33.27 |
6.67 |
3.51 |
H1 2023 |
37.18 |
10.93 |
5.75 |
H2 2023 |
37.13 |
7.66 |
4.03 |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
Q1 2014 | - | - | - | - | - | - | - |
Q2 2014 | - | - | - | - | - | - | - |
Q3 2014 | - | - | - | - | - | - | - |
Q4 2014 | - | - | - | - | - | - | - |
2014 | - | - | - | - | - | - | - |
Q1 2015 | - | - | - | - | - | - | - |
Q2 2015 | - | - | - | - | - | - | - |
Q3 2015 | - | - | - | - | - | - | - |
Q4 2015 | - | - | - | - | - | - | - |
2015 | - | - | - | - | - | - | - |
Q1 2016 | - | - | - | - | - | - | - |
Q2 2016 | - | - | - | - | - | - | - |
Q3 2016 | - | - | - | - | - | - | - |
Q4 2016 | - | - | - | - | - | - | - |
2016 | - | - | - | - | - | - | - |
Q1 2017 | - | - | - | - | - | - | - |
Q2 2017 | - | - | - | - | - | - | - |
Q3 2017 | - | - | - | - | - | - | - |
Q4 2017 | - | - | - | - | - | - | - |
2017 | - | - | - | - | - | - | - |
Q1 2018 | - | - | - | - | - | - | - |
Q2 2018 | - | - | - | - | - | - | - |
Q3 2018 | - | - | - | - | - | - | - |
Q4 2018 | - | - | - | - | - | - | - |
2018 | - | - | - | - | - | - | - |
Q1 2019 | - | - | - | - | - | - | - |
Q2 2019 | - | - | - | - | - | - | - |
Q3 2019 | - | - | - | - | - | - | - |
Q4 2019 | - | - | - | - | - | - | - |
2019 | - | - | - | - | - | - | - |
Q1 2020 | - | - | - | - | - | - | - |
Q2 2020 | - | - | - | - | - | - | - |
Q3 2020 | - | - | - | - | - | - | - |
Q4 2020 | - | - | - | - | - | - | - |
2020 | - | - | - | - | - | - | - |
Q1 2021 | - | - | - | - | - | - | - |
Q2 2021 | - | - | - | - | - | - | - |
Q3 2021 | - | - | - | - | - | - | - |
Q4 2021 | - | - | - | - | - | - | - |
2021 | 40.84 | - | 14.67 | - | (2.21) | - | (0.12) |
Q1 2022 | - | - | - | - | - | - | - |
Q2 2022 | - | - | - | - | - | - | - |
Q3 2022 | - | - | - | - | - | - | - |
Q4 2022 | - | - | - | - | - | - | - |
2022 | 58.57 | 43.4 % | 28.52 | 94.4 % | 10.31 | 567.4 % | 0.54 |
Q1 2023 | - | - | - | - | - | - | - |
Q2 2023 | - | - | - | - | - | - | - |
Q3 2023 | - | - | - | - | - | - | - |
Q4 2023 | - | - | - | - | - | - | - |
2023 | 74.31 | 26.9 % | 40.63 | 42.5 % | 18.59 | 80.3 % | 0.98 |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
2014 | - | - | - | - | - | - | - |
2015 | - | - | - | - | - | - | - |
2016 | - | - | - | - | - | - | - |
2017 | - | - | - | - | - | - | - |
2018 | - | - | - | - | - | - | - |
2019 | - | - | - | - | - | - | - |
2020 | - | - | - | - | - | - | - |
2021 | 40.84 | - | 14.67 | - | (2.21) | - | (0.12) |
2022 | 58.57 | 43.4 % | 28.52 | 94.4 % | 10.31 | 567.4 % | 0.54 |
2023 | 74.31 | 26.9 % | 40.63 | 42.5 % | 18.59 | 80.3 % | 0.98 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | - | - | - |
Q4 2014 | - | - | - |
2014 | - | - | - |
Q1 2015 | - | - | - |
Q2 2015 | - | - | - |
Q3 2015 | - | - | - |
Q4 2015 | - | - | - |
2015 | - | - | - |
Q1 2016 | - | - | - |
Q2 2016 | - | - | - |
Q3 2016 | - | - | - |
Q4 2016 | - | - | - |
2016 | - | - | - |
Q1 2017 | - | - | - |
Q2 2017 | - | - | - |
Q3 2017 | - | - | - |
Q4 2017 | - | - | - |
2017 | - | - | - |
Q1 2018 | - | - | - |
Q2 2018 | - | - | - |
Q3 2018 | - | - | - |
Q4 2018 | - | - | - |
2018 | - | - | - |
Q1 2019 | - | - | - |
Q2 2019 | - | - | - |
Q3 2019 | - | - | - |
Q4 2019 | - | - | - |
2019 | - | - | - |
Q1 2020 | - | - | - |
Q2 2020 | - | - | - |
Q3 2020 | - | - | - |
Q4 2020 | - | - | - |
2020 | - | - | - |
Q1 2021 | - | - | - |
Q2 2021 | - | - | - |
Q3 2021 | - | - | - |
Q4 2021 | - | - | - |
2021 | 35.92 % | 1.28 % | (5.40 %) |
Q1 2022 | - | - | - |
Q2 2022 | - | - | - |
Q3 2022 | - | - | - |
Q4 2022 | - | - | - |
2022 | 48.69 % | 22.19 % | 17.61 % |
Q1 2023 | - | - | - |
Q2 2023 | - | - | - |
Q3 2023 | - | - | - |
Q4 2023 | - | - | - |
2023 | 54.68 % | 29.50 % | 25.02 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | - | - | - |
2020 | - | - | - |
2021 | 35.92 % | 1.28 % | (5.40 %) |
2022 | 48.69 % | 22.19 % | 17.61 % |
2023 | 54.68 % | 29.50 % | 25.02 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | - | - | - |
Q4 2014 | - | - | - |
Q1 2015 | - | - | - |
Q2 2015 | - | - | - |
Q3 2015 | - | - | - |
Q4 2015 | - | - | - |
Q1 2016 | - | - | - |
Q2 2016 | - | - | - |
Q3 2016 | - | - | - |
Q4 2016 | - | - | - |
Q1 2017 | - | - | - |
Q2 2017 | - | - | - |
Q3 2017 | - | - | - |
Q4 2017 | - | - | - |
Q1 2018 | - | - | - |
Q2 2018 | - | - | - |
Q3 2018 | - | - | - |
Q4 2018 | - | - | - |
Q1 2019 | - | - | - |
Q2 2019 | - | - | - |
Q3 2019 | - | - | - |
Q4 2019 | - | - | - |
Q1 2020 | - | - | - |
Q2 2020 | - | - | - |
Q3 2020 | - | - | - |
Q4 2020 | - | - | - |
Q1 2021 | - | - | - |
Q2 2021 | - | - | - |
Q3 2021 | - | - | - |
Q4 2021 | - | - | - |
Q1 2022 | - | - | - |
Q2 2022 | - | - | - |
Q3 2022 | - | - | - |
Q4 2022 | - | - | - |
Q1 2023 | - | - | - |
Q2 2023 | - | - | - |
Q3 2023 | - | - | - |
Q4 2023 | - | - | - |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2014 | - | - | - | - |
Q2 2014 | - | - | - | - |
Q3 2014 | - | - | - | - |
Q4 2014 | - | - | - | - |
Q1 2015 | - | - | - | - |
Q2 2015 | - | - | - | - |
Q3 2015 | - | - | - | - |
Q4 2015 | - | - | - | - |
Q1 2016 | - | - | - | - |
Q2 2016 | - | - | - | - |
Q3 2016 | - | - | - | - |
Q4 2016 | - | - | - | - |
Q1 2017 | - | - | - | - |
Q2 2017 | - | - | - | - |
Q3 2017 | - | - | - | - |
Q4 2017 | - | - | - | - |
Q1 2018 | - | - | - | - |
Q2 2018 | - | - | - | - |
Q3 2018 | - | - | - | - |
Q4 2018 | - | - | - | - |
Q1 2019 | - | - | - | - |
Q2 2019 | - | - | - | - |
Q3 2019 | - | - | - | - |
Q4 2019 | - | - | - | - |
Q1 2020 | - | - | - | - |
Q2 2020 | - | - | - | - |
Q3 2020 | - | - | - | - |
Q4 2020 | - | - | - | - |
Q1 2021 | - | - | - | - |
Q2 2021 | - | - | - | - |
Q3 2021 | - | - | - | - |
Q4 2021 | - | - | - | - |
Q1 2022 | - | - | - | - |
Q2 2022 | - | - | - | - |
Q3 2022 | - | - | - | - |
Q4 2022 | - | - | - | - |
Q1 2023 | - | - | - | - |
Q2 2023 | - | - | - | - |
Q3 2023 | - | - | - | - |
Q4 2023 | - | - | - | - |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2014 | - | - | - | - |
2015 | - | - | - | - |
2016 | - | - | - | - |
2017 | - | - | - | - |
2018 | - | - | - | - |
2019 | - | - | - | - |
2020 | - | - | - | - |
2021 | 19.00 | (0.12) | (0.12) | 1.01 |
2022 | 19.00 | 0.54 | 0.54 | 1.63 |
2023 | 19.00 | 0.98 | 0.98 | 2.07 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | - | - | - |
Q4 2014 | - | - | - |
Q1 2015 | - | - | - |
Q2 2015 | - | - | - |
Q3 2015 | - | - | - |
Q4 2015 | - | - | - |
Q1 2016 | - | - | - |
Q2 2016 | - | - | - |
Q3 2016 | - | - | - |
Q4 2016 | - | - | - |
Q1 2017 | - | - | - |
Q2 2017 | - | - | - |
Q3 2017 | - | - | - |
Q4 2017 | - | - | - |
Q1 2018 | - | - | - |
Q2 2018 | - | - | - |
Q3 2018 | - | - | - |
Q4 2018 | - | - | - |
Q1 2019 | - | - | - |
Q2 2019 | - | - | - |
Q3 2019 | - | - | - |
Q4 2019 | - | - | - |
Q1 2020 | - | - | - |
Q2 2020 | - | - | - |
Q3 2020 | - | - | - |
Q4 2020 | - | - | - |
Q1 2021 | - | - | - |
Q2 2021 | - | - | - |
Q3 2021 | - | - | - |
Q4 2021 | - | - | - |
Q1 2022 | - | - | - |
Q2 2022 | - | - | - |
Q3 2022 | - | - | - |
Q4 2022 | - | - | - |
Q1 2023 | - | - | - |
Q2 2023 | - | - | - |
Q3 2023 | - | - | - |
Q4 2023 | - | - | - |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | - | - | - |
2020 | - | - | - |
2021 | - | - | - |
2022 | - | - | - |
2023 | - | - | - |
2023
2023
Period | Medical Services | Pharmaceutical Products |
---|
Period | Medical Services | Pharmaceutical Products |
---|---|---|
2021 | 38.75 | 2.08 |
2022 | 55.52 | 3.05 |
2023 | 70.91 | 3.40 |
Current | |
Market Cap (M Riyal) | 351.98 |
Enterprise Value (EV) (M) | 358.11 |
Shares Outstanding ((M)) | 23.75 |
Book Value (BV) ( Riyal) | 2.07 |
Par Value ( Riyal) | 1.00 |
Adjusted P/E (Last12) | 18.93 |
Price/book | 8.97 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}